Search

everythinglearnresearchcommunity

for

Search:↓

Trichilemmal carcinoma is rare, usually benign after removal, but needs close follow-up due to recurrence risks.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

The link between pemphigus and the patient's scarring hair loss is still unclear.

There is no standard treatment for CCCA, and practices vary widely.

Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

A specific gene mutation causes severe skin and nail issues and hair loss.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

Surgeons should know about pilomatricoma for accurate diagnosis, even though it's rare.

The young woman has a benign, hereditary skin condition with no signs of a more serious syndrome.

A man developed a rare cancer on his scalp after a hair transplant possibly due to sun damage, laser effects, and inflammation.

Trichostasis spinulosa is a rare skin condition with hair-filled plugs in hair follicles.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Eruptive vellus hair cysts are often missed in diagnoses.

The hair disorder was caused by abnormal protein formation, making hair easily damaged.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Etanercept effectively treated a severe skin condition when other treatments failed.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

A rare skin growth in a baby was successfully removed without coming back.

Hair evaluation is crucial for early diagnosis and management of ARCI, as hair loss often indicates severity.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Nevus comedonicus can sometimes grow terminal hair, challenging previous beliefs.

Keratin 17 gene mutations cause both steatocystoma multiplex and pachyonychia congenita type 2.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.